Your browser doesn't support javascript.
loading
Safety Assessment of Adenosine as Used in Cosmetics.
Cherian, Priya; Bergfeld, Wilma F; Belsito, Donald V; Hill, Ronald A; Klaassen, Curtis D; Liebler, Daniel C; Marks, James G; Shank, Ronald C; Slaga, Thomas J; Snyder, Paul W; Fiume, Monice; Heldreth, Bart.
Afiliação
  • Cherian P; Cosmetic Ingredient Review Senior Scientific Analyst/Writer.
  • Bergfeld WF; Expert Panel for Cosmetic Ingredient Safety Member.
  • Belsito DV; Expert Panel for Cosmetic Ingredient Safety Member.
  • Hill RA; Expert Panel for Cosmetic Ingredient Safety Former Member.
  • Klaassen CD; Expert Panel for Cosmetic Ingredient Safety Member.
  • Liebler DC; Expert Panel for Cosmetic Ingredient Safety Former Member.
  • Marks JG; Expert Panel for Cosmetic Ingredient Safety Former Member.
  • Shank RC; Expert Panel for Cosmetic Ingredient Safety Former Member.
  • Slaga TJ; Expert Panel for Cosmetic Ingredient Safety Member.
  • Snyder PW; Expert Panel for Cosmetic Ingredient Safety Member.
  • Fiume M; Cosmetic Ingredient Review Senior Director.
  • Heldreth B; Cosmetic Ingredient Review Executive Director.
Int J Toxicol ; 43(1_suppl): 50S-63S, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38146080
ABSTRACT
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Adenosine, Adenosine Phosphate, Adenosine Triphosphate, Disodium Adenosine Phosphate, and Disodium Adenosine Triphosphate. These ingredients are reported to function in cosmetics as skin-conditioning agents - miscellaneous. The Panel considered the available data and concluded that the five adenosine ingredients reviewed in this report are safe in cosmetics in the present practices of use and concentration described in this safety assessment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / Cosméticos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / Cosméticos Idioma: En Ano de publicação: 2024 Tipo de documento: Article